Immunovant, Inc. (IMVT)
NASDAQ: IMVT · Real-Time Price · USD
26.54
+0.37 (1.41%)
At close: Nov 21, 2024, 4:00 PM
26.78
+0.24 (0.90%)
After-hours: Nov 21, 2024, 6:06 PM EST

Immunovant Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
207
Market Cap
3.90B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2024---
Mar 31, 2023---
Mar 31, 2022---
Mar 31, 2021---
Mar 31, 2020---
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition